Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Fabio Lopes Pedro is a Brazilian healthcare entity and professional practice led by Dr. Fabio Lopes Pedro, a distinguished infectologist, epidemiologist, and professor of administration. Based in Santa Maria, Rio Grande do Sul, the entity provides specialized medical services in infectious diseases and pediatrics while serving as a prominent site for multicenter clinical trials, including the BENBRASIL trial for Chagas disease and various studies on HIV/AIDS and COVID-19. Dr. Pedro holds leadership roles as a director at Unimed Santa Maria and a professor at the Federal University of Santa Maria (UFSM), where he integrates medical expertise with healthcare management and innovation. The practice operates through private clinical facilities, such as Vivasse Clínica, and collaborates extensively with academic, public health, and cooperative medical networks.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Fabio Lopes Pedro.